Cat.#: ACPP-1306
| Despition | FGFR2 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1522 | Dopamine Receptor D3 Blocking Peptide (AC1522) | 250 µg | inquiry |
| ACPP-1670 | Mouse BDNF Protein (AC1670) | 2 µg | inquiry |
| ACPP-1496 | Human SPINT2 Protein (AC1496) | 2 µg | inquiry |
| ACPP-1097 | Synthetic Nanodisc Human ENTPD2 Protein (AC1097) | 10 µg | inquiry |
| ACPP-1674 | Human KCNIP3 Protein (AC1674) | 5 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
| ACPP-1645 | Human FAM84B Protein (AC1645) | 5 µg | inquiry |
| ACPP-1273 | BTB/POZ domain-containing protein 7 Blocking Peptide (AC1273) | 250 µg | inquiry |
| ACPP-1724 | Human FGF13 Protein (AC1724) | 5 µg | inquiry |
| ACPP-1270 | Luteinizing Hormone Blocking Peptide (AC1270) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.